Literature DB >> 21561617

Multiple trauma induces serum production of host defence peptides.

Sebastian Lippross1, Tim Klueter, Nadine Steubesand, Stefanie Oestern, Rolf Mentlein, Frank Hildebrandt, Rainer Podschun, Thomas Pufe, Andreas Seekamp, Deike Varoga.   

Abstract

Today multiple trauma still is associated with a high mortality. Although severe open fractures and wounds can give rise to local infections and sepsis, the overall infection rate of multiply injured patients is surprisingly low. We have investigated serum of multiply injured patients with respect to antibacterial properties and screened for host defence peptides (HDP) that constitute a class of fast acting and rapidly available molecules preventing bacterial infection. Serum specimens were obtained from multiply injured patients. Radial diffusion assays were performed to investigate antimicrobial properties. Ultrafiltration and heat-inactivation were used to rule out antimicrobial activity of large proteins i.e. complement factors. ELISA was performed to analyse serum concentrations of the human beta-defensins 2 and 3 (hBD-2 and hBD-3), LL-37 and the proinflammatory cytokines interferon-gamma (IFN-γ) and interleukin-6 (IL-6). Serum of multiply injured patients showed greater zones of inhibition in antimicrobial testing against Gram negative und positive bacteria. This effect was mediated by proteins smaller than 10 kDa, inactivation of the complement system does not significantly reduce antibacterial action. hBD-2, hBD-3 and LL-37 concentrations were significantly elevated after trauma and followed different characteristic concentration curves. Similar patterns of concentration profiles were recorded for hBD-2/IL-6 and hBD-3/IFN-γ suggesting a stimulatory influence within their induction process. With this study we provide evidence, that serum of multiply injured patients has by far higher antibacterial capacity than that of healthy donors. As possible mediators we have detected the HDP hBD-2, hBD-3 and LL-37 and their inducers in serum of multiply injured patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21561617     DOI: 10.1016/j.injury.2011.03.044

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  13 in total

1.  Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.

Authors:  Maria Rapala-Kozik; Oliwia Bochenska; Marcin Zawrotniak; Natalia Wolak; Grzegorz Trebacz; Mariusz Gogol; Dominika Ostrowska; Wataru Aoki; Mitsuyoshi Ueda; Andrzej Kozik
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

2.  Copy Number Variation within Human β-Defensin Gene Cluster Influences Progression to AIDS in the Multicenter AIDS Cohort Study.

Authors:  Rajeev K Mehlotra; Jean-Eudes Dazard; Bangan John; Peter A Zimmerman; Aaron Weinberg; Richard J Jurevic
Journal:  J AIDS Clin Res       Date:  2012

3.  Human serum triggers antibiotic tolerance in Staphylococcus aureus.

Authors:  Elizabeth V K Ledger; Stéphane Mesnage; Andrew M Edwards
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 17.694

Review 4.  Antimicrobial peptides and their potential application in inflammation and sepsis.

Authors:  Tobias Schuerholz; Klaus Brandenburg; Gernot Marx
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

Review 5.  Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?

Authors:  Miriam D Neher; Sebastian Weckbach; Michael A Flierl; Markus S Huber-Lang; Philip F Stahel
Journal:  J Biomed Sci       Date:  2011-11-30       Impact factor: 8.410

6.  The potential role of increasing the release of mouse β- defensin-14 in the treatment of osteomyelitis in mice: a primary study.

Authors:  Chen Zhu; Jiaxing Wang; Tao Cheng; Qingtian Li; Hao Shen; Hui Qin; Mengqi Cheng; Xianlong Zhang
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

7.  The antimicrobial peptide lysozyme is induced after multiple trauma.

Authors:  Tim Klüter; Stefanie Fitschen-Oestern; Sebastian Lippross; Matthias Weuster; Rolf Mentlein; Nadine Steubesand; Claudia Neunaber; Frank Hildebrand; Thomas Pufe; Mersedeh Tohidnezhad; Andreas Beyer; Andreas Seekamp; Deike Varoga
Journal:  Mediators Inflamm       Date:  2014-08-31       Impact factor: 4.711

8.  Vitamin D nutritional status and vitamin D regulated antimicrobial peptides in serum and pleural fluid of patients with infectious and noninfectious pleural effusions.

Authors:  Carlos A Amado; María T García-Unzueta; M Carmen Fariñas; Francisca Santos; María Ortiz; Pedro Muñoz-Cacho; José A Amado
Journal:  BMC Pulm Med       Date:  2016-07-08       Impact factor: 3.317

9.  The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.

Authors:  Allen J Duplantier; Monique L van Hoek
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

10.  Defensin DEFB103 bidirectionally regulates chemokine and cytokine responses to a pro-inflammatory stimulus.

Authors:  Lauren E Harvey; Karl G Kohlgraf; Leslie A Mehalick; Monica Raina; Erica N Recker; Saumya Radhakrishnan; Samiksha Avinash Prasad; Robinson Vidva; Ann Progulske-Fox; Joseph E Cavanaugh; Shireen Vali; Kim A Brogden
Journal:  Sci Rep       Date:  2013-02-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.